Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Roilides

Showing results (301-310 of 337) with videos related to

Pageof 34
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
Mayo Clinic Proceedings|October 8, 2016
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing EnterobacteriaceaeBelén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
The Lancet. Infectious Diseases|April 27, 2017
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
Eclinicalmedicine|March 10, 2023
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, et al.
Mycopathologia|June 10, 2025
A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022Anna Skiada, Maria Drogari-Apiranthitou, Emmanuel Roilides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2022
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and AdolescentsBrian T Fisher, Craig L K Boge, Rui Xiao, et al.
Emerging Infectious Diseases|July 18, 2018
Toxoplasmosis in Transplant Recipients, Europe, 2010-2014Florence Robert-Gangneux, Valeria Meroni, Damien Dupont, et al.
The Pediatric Infectious Disease Journal|June 25, 2024
Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence StudyElisavet Chorafa, Elias Iosifidis, Andrea Oletto, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2025
Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)Elisavet Chorafa, Elias Iosifidis, Andrea Oletto, et al.
Pageof 34

Showing results (301-310 of 337) with videos related to

Sort By:
Pageof 34
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
Mayo Clinic Proceedings|October 8, 2016
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing EnterobacteriaceaeBelén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
The Lancet. Infectious Diseases|April 27, 2017
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
Eclinicalmedicine|March 10, 2023
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, et al.
Mycopathologia|June 10, 2025
A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022Anna Skiada, Maria Drogari-Apiranthitou, Emmanuel Roilides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2022
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and AdolescentsBrian T Fisher, Craig L K Boge, Rui Xiao, et al.
Emerging Infectious Diseases|July 18, 2018
Toxoplasmosis in Transplant Recipients, Europe, 2010-2014Florence Robert-Gangneux, Valeria Meroni, Damien Dupont, et al.
The Pediatric Infectious Disease Journal|June 25, 2024
Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence StudyElisavet Chorafa, Elias Iosifidis, Andrea Oletto, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2025
Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)Elisavet Chorafa, Elias Iosifidis, Andrea Oletto, et al.
Pageof 34